Firstly, we used bioinformatics methods to find a positive correlation between LRRC59 expression and dendritic resting cell, as well as T regulatory cell in HCC, which meant that HCC patients with LRRC59 overexpression may be poor responsive to immunotherapy [34]. This evidence concerns the gene LRRC59 and hepatocellular carcinoma.